ClinicalTrials.gg
CompletedNCT04655950SPONDIMMOUpdated Dec 7, 2020

Immobilization and Neurological Complications in Patients With Vertebral Osteomyelitis.

An observational study in Vertebral Osteomyelitis and Spondylodiscitis, sponsored by Nantes University Hospital. Completed at 9 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-12-07.

Sponsored by Nantes University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

Vertebral osteomyelitis is an infection of the intervertebral disk and adjacent vertebral plates with a non-negligible risk of neurological complications and handicap. If there are clear recommendations dealing with antibiotic therapy and surgery indications for this pathogen, the question of the immobilization will be remaining debate. The aim of the study was to describe protocols and practices for the immobilization of vertebral osteomyelitis in different French hospitals and bone and joint infections Centers. The secondary objectives were to evaluate the frequency of neurological complications in a large prospective cohort, and to identify clinical and imaging risk factors for neurological complications.

The investigators also aim to search for association between type and duration of spine immobilization and neurological status at the end of follow-up.

Read the detailed description

Study design is descriptive, prospective, multicentric, and the investigators have a single database centralized in Nantes University Hospital. Patient's data will be conserved and trapped anonymously and patients all give oral consent. Information letter is given to each patient.

Typical study calendar :

Baseline :

  • Patient information (letter and oral consent)
  • Clinical data and comorbidities collection
  • Neurological examination
  • Spine X-ray
  • MRI or CT-scan imaging to confirm diagnosis

During Hospitalization

  • Date collection : spine immobilization modalities (type, duration, changes...), duration of bed rest
  • Other treatments (antibiotic therapy : molecules and duration)
  • Daily neurological examination

    3 months follow-up visit : (if usually done by physician)

  • Clinical and neurological examination
  • Spine immobilization assessment
  • Spine X-ray
  • Oswestry questionary

    6 months follow-up visit : finale visit (if usually done by physician)

  • Clinical and neurological examination
  • Spine immobilization assessment
  • Spine X-ray
  • Oswestry questionary
02

Conditions studied

  • Vertebral Osteomyelitis
  • Spondylodiscitis

Browse trials for

Keywords

  • Vertebral Osteomyelitis
  • Spine Immobilization
  • Neurological complications
03

In context

Discitis

24 studies on the registry are indexed under Discitis; 5 are open to participants now.

This study's enrollment of 250 is above the median of 104 across 16 observational studies indexed under Discitis.

Browse Discitis studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 839 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Baseline :

  • Patient information (letter and oral consent)
  • Clinical data and comorbidities collection
  • Neurological examination
  • Spine X-ray
  • MRI or CT-scan imaging to confirm diagnosis

During Hospitalization

  • Date collection : spine immobilization modalities (type, duration, changes...), duration of bed rest
  • Other treatments (antibiotic therapy : molecules and duration)
  • Daily neurological examination

    3 months follow-up visit : (if usually done by physician)

  • Clinical and neurological examination
  • Spine immobilization assessment
  • Spine X-ray
  • Oswestry questionnary

    6 months follow-up visit : finale visit (if usually done by physician)

  • Clinical and neurological examination
  • Spine immobilization assessment
  • Spine X-ray
  • Oswestry questionnary

Eligibility criteria

Inclusion Criteria:

  • Adults patients, male and female
  • Hospitalized of a vertebral osteomyelitis in one of the Centers
  • Meeting the criteria for the definition of vertebral Osteomyelitis (typical imaging findings)
  • Microbiological proof of infection (blood culture or discovertebral ) or high suspicion of infection (Compatible histology, good response to antibiotics and no differential diagnosis).

Exclusion Criteria:- Spine device infection

  • Recent spinal surgery less than 1month
  • Children under 18 years old
  • Under guardianship
  • Pregnant woman
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
250 participants (actual)
Target follow-up
6 Months
Patient registry
Yes

Interventions

  • Otherprotocols and practices for the immobilization of vertebral osteomyelitis in different French hospitals and bone and joint infections Centers

    Evaluation of the frequency of neurological complications in a large prospective cohort, and to identify clinical and imaging risk factors for neurological complications. We search for association between type and duration of spine immobilization and neurological status at the end of follow-up

06

What researchers measure

Primary outcomes

  1. Qualitative description of main types of spine immobilization

    Type of bracing : smooth or rigid bracing, highness of bracing (cervical, thoracic, lumbar spine or both and level of the highest and lowest vertebrae included).

    Time frame: inclusion

Secondary outcomes

  1. Frequency of neurological complications

    Percentage of neurological complication at baseline, 3 and 6 months follow-up) * Percentage of major neurological signs (sphincter dysfunction and/or motor deficit and ASIA score) at baseline, 3 and 6 months follow-up * Percentage of minor neurological signs (radicular pain, reflex abolition, hypoesthesia) at baseline, 3 and 6 months follow-up

    Time frame: inclusion, month 3 and month 6

  2. MRI signs at baseline

    Number of vertebrae involved, destruction of posterior arch, destruction of vertebrae, kyphosis, epidural phlegmon, spinal cord hypersignal, dural sac compression, anterior effacement of subarachnoidal space Oswestry functional score at 3 and 6 months follow-up. Association between type and duration of spine immobilization and neurological complication

    Time frame: inclusion, month 3 and month 6

  3. Oswestry functional score at 3 and 6 months follow-up

    Association between type and duration of spine immobilization and neurological complication

    Time frame: inclusion, month 3 and month 6

  4. Duration of Spine immobilization

    Evaluation of the duration of immobilization of the spine

    Time frame: month 6

07

Study locations

9 sites
  • Angers University Hospital
    Angers, 49000, France
  • Clermont ferrand University Hospital
    Clermont-Ferrand, 63000, France
  • La Roche Sur Yon Hospital
    La Roche-sur-Yon, 85000, France
  • Nantes University Hospital
    Nantes, 44000, France
  • Paris University Hospital
    Paris, 75020, France
  • Quimper Hospital
    Quimper, 29107, France
  • Rennes University Hospital
    Rennes, 35000, France
  • Saint-Nazaire Hospital
    Saint-Nazaire, 44606, France
  • Tours University Hospital
    Tours, 37000, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2016 to primary completion in May 2019, 39 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2020
First posted
Dec 7, 2020
StartActual
Feb 11, 2016
Primary completionActual
May 31, 2019
CompletionActual
May 31, 2019
Last update
Dec 7, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 7, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04655950
Responsible party
Sponsor
First posted
Dec 7, 2020
Start date
Feb 11, 2016
Primary completion
May 31, 2019
Completion
May 31, 2019
Last update
Dec 7, 2020

Study contacts

Benoit Le Goff, PH
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion